FLAM
First Light Asset Management Portfolio holdings
AUM
$771M
This Quarter Return
+14.65%
1 Year Return
+33.17%
3 Year Return
+208.13%
5 Year Return
+426.73%
10 Year Return
+3,318.8%
AUM
$262M
AUM Growth
+$262M
(+15%)
Cap. Flow
+$9M
Cap. Flow
% of AUM
3.44%
Top 10 Holdings %
Top 10 Hldgs %
48.69%
Holding
59
New
5
Increased
14
Reduced
24
Closed
7
Top Buys
| 1 |
XENT
Intersect ENT, Inc
XENT
|
$11.4M |
| 2 |
AKRX
Akorn, Inc.
AKRX
|
$5.8M |
| 3 |
Heron Therapeutics
HRTX
|
$5.46M |
| 4 |
Omnicell
OMCL
|
$5.44M |
| 5 |
Halozyme
HALO
|
$5.37M |
Top Sells
| 1 |
TEAR
TearLab Corporation
TEAR
|
$8.35M |
| 2 |
LHCG
LHC Group LLC
LHCG
|
$5.06M |
| 3 |
ARRY
Array Biopharma Inc
ARRY
|
$3.88M |
| 4 |
PETX
Aratana Therapeutics, Inc.
PETX
|
$2.95M |
| 5 |
DOC
PHYSICIANS REALTY TRUST
DOC
|
$2.9M |
Sector Composition
| 1 | Healthcare | 73.96% |
| 2 | Energy | 2.6% |
| 3 | Communication Services | 1.68% |
| 4 | Real Estate | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
NeoGenomics
NEO
$1.13B
| $20.9M | 7.99% | 2,653,654 +79,763 | +3% | +$629K |
|
|
AKRX
2
DELISTED
Akorn, Inc.
AKRX
| $18.7M | 7.13% | 775,591 +241,067 | +45% | +$5.8M |
|
3
AtriCure
ATRC
$1.84B
| $18.3M | 6.99% | 956,458 +17,446 | +2% | +$334K |
|
|
IMMU
4
DELISTED
Immunomedics Inc
IMMU
| $13.6M | 5.18% | 2,096,495 -185,514 | -8% | -$1.2M |
|
|
XENT
5
DELISTED
Intersect ENT, Inc
XENT
| $11.4M | 4.37% | +667,504 | New | +$11.4M |
|
|
SHPG
6
DELISTED
Shire pic
SHPG
| $9.72M | 3.71% | 55,791 +18,543 | +50% | +$3.23M |
|
|
OXFD
7
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $9.64M | 3.68% | 622,238 -125,401 | -17% | -$1.94M |
|
|
ENZ
8
DELISTED
Enzo Biochem, Inc.
ENZ
| $9.39M | 3.58% | 1,121,736 +114,379 | +11% | +$957K |
|
9
Harvard Bioscience
HBIO
$22M
| $8.33M | 3.18% | 3,204,485 +460,357 | +17% | +$1.2M |
|
10
HealthStream
HSTM
$832M
| $7.51M | 2.87% | 309,931 +5,631 | +2% | +$136K |
|
|
TLGT
11
DELISTED
Teligent, Inc
TLGT
| $7.42M | 2.83% | 949,377 -8,311 | -0.9% | -$64.9K |
|
|
LHCG
12
DELISTED
LHC Group LLC
LHCG
| $6.8M | 2.6% | 126,123 -93,869 | -43% | -$5.06M |
|
|
MDCO
13
DELISTED
Medicines Co
MDCO
| $6.69M | 2.55% | 136,739 +9,014 | +7% | +$441K |
|
|
SAGE
14
DELISTED
Sage Therapeutics
SAGE
| $6.64M | 2.54% | 93,465 -679 | -0.7% | -$48.3K |
|
15
Ligand Pharmaceuticals
LGND
$3.15B
| $6.63M | 2.53% | 62,640 +21,450 | +52% | +$2.27M |
|
16
Veracyte
VCYT
$2.39B
| $6.62M | 2.53% | 720,878 +28,668 | +4% | +$263K |
|
|
ENTL
17
DELISTED
Entellus Medical, Inc. Common Stock
ENTL
| $5.62M | 2.15% | 407,497 +16,208 | +4% | +$224K |
|
|
KTWO
18
DELISTED
K2M Group Holdings, Inc
KTWO
| $5.57M | 2.13% | 271,698 -2,720 | -1% | -$55.8K |
|
|
19
Heron Therapeutics
HRTX
$207M
| $5.46M | 2.08% | +363,689 | New | +$5.46M |
|
|
20
Omnicell
OMCL
$1.5B
| $5.44M | 2.08% | +133,823 | New | +$5.44M |
|
|
21
Halozyme
HALO
$8.56B
| $5.37M | 2.05% | +414,611 | New | +$5.37M |
|
|
SPNC
22
DELISTED
Spectranetics Corp
SPNC
| $5.31M | 2.03% | 182,156 -1,571 | -0.9% | -$45.8K |
|
23
Nektar Therapeutics
NKTR
$568M
| $5.24M | 2% | +223,421 | New | +$5.24M |
|
|
ARRY
24
DELISTED
Array Biopharma Inc
ARRY
| $5.06M | 1.93% | 566,332 -434,029 | -43% | -$3.88M |
|
|
AMED
25
DELISTED
Amedisys
AMED
| $4.73M | 1.81% | 92,549 -24,730 | -21% | -$1.26M |
|